References
- Cohen S, Yoshioka T, Lucarelli M, et al. Controlled delivery systems for proteins based on poly (lactic/glycolic acid) microspheres. Pharmaceut Res 1991;8:713–720
- Andreas K, Zehbe R, Kazubek M, et al. Biodegradable insulin-loaded PLGA microspheres fabricated by three different emulsification techniques: investigation for cartilage tissue engineering. Acta Biomater 2011;7:1485–1495
- Paillard-Giteau A, Tran V, Thomas O, et al. Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique. Eur J Pharm Biopharm 2010;75:128–136
- Kumar L, Verma S, Jamwal S, et al. Polymeric microparticles-based formulation for the eradication of cutaneous candidiasis: development and characterization. Pharm Dev Technol 2013; in press, doi:10.3109/10837450.2013.778874
- Song X, Song S-K, Zhao P, et al. β-methasone-containing biodegradable poly (lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release. Pharm Dev Technol 2013; in press, doi:10.3109/10837450.2011.635152
- Zaghloul A-A, Mustafa F, Siddiqui A, Khan M. Response surface methodology to obtain β-estradiol biodegradable microspheres for long-term therapy of osteoporosis. Pharm Dev Technol 2006;11:377–387
- Chen RR, Mooney DJ. Polymeric growth factor delivery strategies for tissue engineering. Pharmaceut Res 2003;20:1103–1112
- Fu K, Harrell R, Zinski K, et al. A potential approach for decreasing the burst effect of protein from PLGA microspheres. J Pharm Sci 2003;92:1582–1591
- Jain RA. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475–2490
- Yang YY, Chung TS, Ping Ng N. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001;22:231–241
- Ravi S, Peh K, Darwis Y, et al. Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system. Indian J Pharm Sci 2008;70:303--309
- Sandor M, Enscore D, Weston P, Mathiowitz E. Effect of protein molecular weight on release from micron-sized PLGA microspheres. J Control Release 2001;76:297–311
- Mao S, Xu J, Cai C, et al. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm 2007;334:137–148
- Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release 2010;146:241–260
- Park W, Na K. Polyelectrolyte complex of chondroitin sulfate and peptide with lower pI value in poly (lactide-co-glycolide) microsphere for stability and controlled release. Colloids Surf B: Biointerfaces 2009;72:193–200
- Schoubben A, Blasi P, Giovagnoli S, et al. Novel composite microparticles for protein stabilization and delivery. Eur J Pharm Sci 2009;36:226–234
- Ho ML, Fu YC, Wang GJ, et al. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite. J Control Release 2008;128:142–148
- Yamaguchi Y, Takenaga M, Kitagawa A, et al. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives. J Control Release 2002;81:235–249
- Luan X, Skupin M, Siepmann J, Bodmeier R. Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles. Int J Pharm 2006;324:168–175
- Hrynyk M, Martins-Green M, Barron AE, Neufeld RJ. Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds. Int J Pharm 2010;398:146–154
- Ruan G, Feng SS, Li QT. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J Control Release 2002;84:151–160
- Zhang H, Lu Y, Zhang G, et al. Bupivacaine-loaded biodegradable poly (lactic-co-glycolic) acid microspheres: I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Int J Pharm 2008;351:244–249
- Hedberg EL, Shih CK, Solchaga LA, et al. Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers. J Control Release 2004;100:257--266
- Rojas J, Pinto-Alphandary H, Leo E, et al. Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres. Int J Pharm 1999;183:67–71
- Box GEP, Behnken D. Some new three level designs for the study of quantitative variables. Technometrics 1960;2:455–475
- He JT, Su HB, Li GP, et al. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly (lactic-co-glycolic acid) microspheres. Int J Pharm 2006;309:101–108
- van de Weert M, Hoechstetter J, Hennink WE, Crommelin DJA. The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release 2000;68:351–359